Astera Labs, Inc. Common Stock logo ALAB - Astera Labs, Inc. Common Stock

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $277.73 DETAILS
HIGH: $460.00
LOW: $153.00
MEDIAN: $270.00
CONSENSUS: $277.73
DOWNSIDE: 39.09%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

High-Growth Software 80% confidence

Primary model: Revenue × Terminal Margin DCF

Valuation Signal Overvalued Strong
Trading 284.7% above fair value
Current Price $455.96
Bear Case $58.47 87.2% downside ($58.47 - $455.96) / $455.96 = -87.2% 18% rev growth, 21% terminal margin
Fair Value $118.52 74.0% downside ($118.52 - $455.96) / $455.96 = -74.0% 30% rev growth, 28% terminal margin
Bull Case $165.19 63.8% downside ($165.19 - $455.96) / $455.96 = -63.8% 35% rev growth, 32% terminal margin

Adjust Assumptions

30.0%
28.0%
12.0%

Key Value Driver

Revenue growth (30%) × margin expansion to 28%

Terminal Value % of EV 56%
Implied Market Multiple 90.3x

Plain-Language Summary

Our base-case estimate uses a discounted cash flow model based on revenue growth and long-run free cash flow margins. We then blend that result with the average analyst price target of $277.73 from 17 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $118.52 per share.

Warnings

Gross margin of 76% means each dollar of revenue is highly profitable. As the company grows, overhead costs should shrink as a share of revenue, boosting overall profits.
Wall Street's average price target is $277.73 (from 17 analysts). Our estimate is 76% below the consensus -- consider that gap carefully.

Key Risks

  • Current FCF misleads — the model values future margins, not today's cash
  • SBC dilution is the hidden tax: 2-4% annual share growth compounds fast
  • Revenue deceleration is inevitable — the question is when and how steep